Recently developed radiopharmaceuticals for Positron Emission Tomography (PET)

Positron Emission Tomography (PET) is an improving technology and it is a promising field for the diagnosis of the diseases in relatively early stages. It can also be used for tracing the therapy by obtaining metabolic information and it can supply quantitative results. The use of analogues of naturally existing elements as radionuclides made PET a desirable Nuclear Medicine imaging technique. The scope of this review is to touch upon most of the PET radiopharmaceuticals especially the recently developed ones. Some of them are used in preclinical studies and researches and others are used in clinical studies for imaging of various cancers and infections, and only few of them can be used for therapy. Besides the importance of current Good Manufacturing Practices (cGMP) of applications of PET radiopharmaceuticals was underscored.